Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention  Cancer Health Disparities Conference 2009
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 42, 2255-2259, June 1, 1982]
© 1982 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by MacEwen, E. G.
Right arrow Articles by Panko, W. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by MacEwen, E. G.
Right arrow Articles by Panko, W. B.

Estrogen Receptors in Canine Mammary Tumors1

E. G. MacEwen2, A. K. Patnaik, H. J. Harvey and W. B. Panko

Departments of Oncology [E. G. M.] and Pathology [A. K. P.], The Animal Medical Center, New York, New York 10021; Cornell University, New York State College of Veterinary Medicine, Ithaca, New York 14853 [H. J. H.], and Baylor College of Medicine, Houston, Texas 77029 [W. B. P.]

The presence of estrogen receptor in 67 canine mammary lesions was correlated with pathological features of the disease. All tissue specimens were analyzed for estrogen receptor content by a sucrose gradient ultracentrifugation method previously used in analyzing human breast cancer cytosols. Pathological features of the tissues were assessed by a veterinary pathologist without knowledge of results of estrogen receptor analysis. Sixty-two (92.5%) of the tissue samples analyzed were classified as epithelial neoplastic lesions, and 38 of these (61.3%), including 24 adenocarcinomas, were estrogen receptor positive (i.e., estrogen receptor concentration equal to or greater than 10 fmol/mg cytosol protein). All five of the nonepithelial neoplastic lesions were estrogen receptor negative.

Canine and human breast cancers share common histological types and have similar biological behavior. If a significant percentage of canine mammary cancer is also estrogen dependent, the dog may be a useful model for hormonal studies and for the development of models of endocrine therapy for human breast cancer.

1 This work was supported by Grants CA-19072, CA-25586, and CA-26452 from The National Cancer Institute, the Cancer Research Institute, and The Bodman Foundation. A preliminary report of these data was presented at the First International Congress on Hormones and Cancer, October 3 to 6, 1979, at Rome, Italy [S. Iacobelli, R. J. B. King, H. R. Lindner, and M. E. Lippman (eds.), Hormones and Cancer. New York: Raven Press, 1980].

2 To whom requests for reprints should be addressed, at The Animal Medical Center; 510 E. 62nd St., New York, N. Y. 10021.

Received 6/18/81. Accepted 3/ 2/82.




This article has been cited by other articles:


Home page
Vet PatholHome page
A. Nieto, L. Pena, M. D. Perez-Alenza, M. A. Sanchez, J. M. Flores, and M. Castano
Immunohistologic Detection of Estrogen Receptor Alpha in Canine Mammary Tumors: Clinical and Pathologic Associations and Prognostic Significance
Vet. Pathol., May 1, 2000; 37(3): 239 - 247.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1982 by the American Association for Cancer Research.